Fiche centre
Xuanwu Hospital ,Capital Medical University
Beijing — China
Essais liés3clinical trials
VilleBeijinglocalisation
PaysChinalocalisation
SourcelocaleCSV/MySQL
Informations
centreSynchronisé depuis ClinicalTrials.gov — NCT07905352
Essais cliniques associés
3| Molécule | Indication / population | Phase | NCT | Titre | Statut |
|---|---|---|---|---|---|
| Simenafil Hydrochloride Tablets 2.5 mg | Alzheimer | Phase 2 | NCT07905352 | A Phase 2 Clinical Study of Simenafil Hydrochloride Tablets in the Treatment of Alzheimer's Disease | NOT_YET_RECRUITING |
| NIDBase — National, Multicentric Registry Study on Neuroimmunological Diseases in China | SEP | À vérifier | NCT06443333 | NIDBase — National, Multicentric Registry Study on Neuroimmunological Diseases in China | UNKNOWN |
| Nipocalimab | Myasthénie | Phase 3 | NCT04951622 | A Study of Nipocalimab Administered to Adults With Generalized Myasthenia Gravis | RECRUITING |